The relation of leptin and insulin with obesity-related cardiovascular risk factors in US adults

Atherosclerosis

Volumn 200, Issue 1, 2008, Pages 150-160

  Reis, Jared P ^a,b   Macera, Caroline A ^b   Wingard, Deborah L ^a   Araneta, Maria Rosario G ^a   Lindsay, Suzanne P ^b   Marshall, Simon J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

Cardiovascular disease; Inflammation; Leptin; Risk factors

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; FEMALE; HUMAN; INFLAMMATORY DISEASE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MULTIVARIATE ANALYSIS; OBESITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; THROMBOGENESIS; UNITED STATES; WAIST CIRCUMFERENCE;

ADULT; AGED; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; FEMALE; FIBRINOGEN; HUMANS; INSULIN; LEPTIN; MALE; MIDDLE AGED; NUTRITION SURVEYS; OBESITY; RISK FACTORS; SEX FACTORS; UNITED STATES;

EID: 49749093473     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.11.015     Document Type: Article

References (71)

1. World Health Organization. http://www.who.int/bmi/index.jsp.
2. Flegal K.M., Carroll M.D., Ogden C.L., and Johnson C.L. Prevalence and trends in obesity among US adults 1999-2000. JAMA 288 (2002) 1723-1727
3. Willett W.C., Manson J.E., Stampfer M.J., et al. Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range. JAMA 273 (1995) 461-465
4. Hubert H.B., Feinleib M., McNamara P.M., and Castelli W.P. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67 (1983) 968-977
5. Havlik R.J., Hubert H.B., Fabsitz R.R., and Feinleib M. Weight and hypertension. Ann Intern Med 98 (1983) 855-859
6. Ashley Jr. F.W., and Kannel W.B. Relation of weight change to changes in atherogenic traits: the Framingham Study. J Chron Dis 27 (1974) 103-114
7. Chan J.M., Rimm E.B., Colditz G.A., Stampfer M.J., and Willett W.C. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diab Care 17 (1994) 961-969
8. Davis B.R., Blaufox M.D., Oberman A., et al. Reduction in long-term antihypertensive medication requirements Effects of weight reduction by dietary intervention in overweight persons with mild hypertension. Arch Intern Med 153 (1993) 1773-1782
9. King A.C., Haskell W.L., Taylor C.B., Kraemer H.C., and DeBusk R.F. Group- vs home-based exercise training in healthy older men and women. A community-based clinical trial. JAMA 266 (1991) 1535-1542
10. Schuler G., Hambrecht R., Schlierf G., et al. Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease. Circulation 86 (1992) 1-11
11. Manning R.M., Jung R.T., Leese G.P., and Newton R.W. The comparison of four weight reduction strategies aimed at overweight diabetic patients. Diab Med 12 (1995) 409-415
12. Brennan A.M., Li T.Y., Kelesidis I., et al. Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: a prospective cohort study. Diabetologia 50 (2007) 1178-1185
13. Soderberg S., Ahren B., Stegmayr B., et al. Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort. Stroke 30 (1999) 328-337
14. Soderberg S., Stegmayr B., Ahlbeck-Glader C., et al. High leptin levels are associated with stroke. Cerebrovasc Dis 15 (2003) 63-69
15. Soderberg S., Stegmayr B., Stenlund H., et al. Leptin, but not adiponectin, predicts stroke in males. J Intern Med 256 (2004) 128-136
16. Soderberg S., Ahren B., Jansson J.H., et al. Leptin is associated with increased risk of myocardial infarction. J Intern Med 246 (1999) 409-418
17. Wallace A.M., McMahon A.D., Packard C.J., et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 104 (2001) 3052-3056
18. Bouloumie A., Drexler H.C., Lafontan M., and Busse R. Leptin, the product of Ob gene, promotes angiogenesis. Circ Res 83 (1998) 1059-1066
19. Bouloumie A., Marumo T., Lafontan M., and Busse R. Leptin induces oxidative stress in human endothelial cells. FASEB J 13 (1999) 1231-1238
20. Parhami F., Tintut Y., Ballard A., Fogelman A.M., and Demer L.L. Leptin enhances the calcification of vascular cells: artery wall as a target of leptin. Circ Res 88 (2001) 954-960
21. Sierra-Honigmann M.R., Nath A.K., Murakami C., et al. Biological action of leptin as an angiogenic factor. Science 281 (1998) 1683-1686
22. Haffner S.M., Mykkanen L., Rainwater D.L., Karhapaa P., and Laakso M. Is leptin concentration associated with the insulin resistance syndrome in nondiabetic men?. Obes Res 7 (1999) 164-169
23. Kazumi T., Kawaguchi A., Hirano T., and Yoshino G. C-reactive protein in young, apparently healthy men: associations with serum leptin, QTc interval, and high-density lipoprotein-cholesterol. Metabolism 52 (2003) 1113-1116
24. Shamsuzzaman A.S., Winnicki M., Wolk R., et al. Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation 109 (2004) 2181-2185
25. Wannamethee S.G., Tchernova J., Whincup P., et al. Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis 191 (2006) 418-426
26. Leyva F., Godsland I.F., Ghatei M., et al. Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol 18 (1998) 928-933
27. Al-Daghri N., Al-Rubean K., Bartlett W.A., et al. Serum leptin is elevated in Saudi Arabian patients with metabolic syndrome and coronary artery disease. Diab Med 20 (2003) 832-837
28. Karter A.J., D'Agostino Jr. R.B., Mayer-Davis E.J., et al. Abdominal obesity predicts declining insulin sensitivity in non-obese normoglycaemics: the Insulin Resistance Atherosclerosis Study (IRAS). Diab Obes Metab 7 (2005) 230-238
29. Karter A.J., Mayer-Davis E.J., Selby J.V., et al. Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insulin Resistance and Atherosclerosis Study. Diabetes 45 (1996) 1547-1555
30. Lillioja S., Mott D.M., Spraul M., et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329 (1993) 1988-1992
31. Martin B.C., Warram J.H., Krolewski A.S., et al. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340 (1992) 925-929
32. Weyer C., Hanson R.L., Tataranni P.A., Bogardus C., and Pratley R.E. A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. Diabetes 49 (2000) 2094-2101
33. Pyorala M., Miettinen H., Laakso M., and Pyorala K. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Circulation 98 (1998) 398-404
34. Welin L., Bresater L.E., Eriksson H., et al. Insulin resistance and other risk factors for coronary heart disease in elderly men. The Study of Men Born in 1913 and 1923. Eur J Cardiovasc Prev Rehabil 10 (2003) 283-288
35. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428
36. Liu Q.Z., Knowler W.C., Nelson R.G., et al. Insulin treatment, endogenous insulin concentration, and ECG abnormalities in diabetic Pima Indians. Cross-sectional and prospective analyses. Diabetes 41 (1992) 1141-1150
37. Ferrara A., Barrett-Connor E.L., and Edelstein S.L. Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: the Rancho Bernardo Study 1984-1991. Am J Epidemiol 140 (1994) 857-869
38. Orchard T.J., Eichner J., Kuller L.H., et al. Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype. A report from the Multiple Risk Factor Intervention Trial. Ann Epidemiol 4 (1994) 40-45
39. Ford E.S., and Giles W.H. Serum vitamins, carotenoids, and angina pectoris: findings from the National Health and Nutrition Examination Survey III. Ann Epidemiol 10 (2000) 106-116
40. Frohlich E.D., Grim C., and Labarthe D.R. Recommendations for human blood pressure determination by sphygmomanometers. Hypertension 11 (1988) 210A-222A
41. Gunter E.W., Lewis B.G., and Koncikowski S.M. Laboratory procedures used for the third National Health and Nutrition Examination Survey (NHANES III), 1988-1994 (1996), Centers for Disease Control and Prevention, Hyattsville, MD
42. Ma Z., Gingerich R.L., Santiago J.V., et al. Radioimmunoassay of leptin in human plasma. Clin Chem 42 (1996) 942-946
43. Lissner L., Karlsson C., Lindroos A.K., et al. Birth weight, adulthood BMI, and subsequent weight gain in relation to leptin levels in Swedish women. Obes Res 7 (1999) 150-154
44. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
45. Bachorik P.S., Lovejoy K.L., Carroll M.D., et al. Measurement of apolipoproteins A-I and B during the National Health and Nutrition Examination Survey (NHANES) III. Clin Chem 40 (1994) 1915-1920
46. National Center for Health Statistics. Plan and operation of the third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collections procedures. Vital Health Stat 1 (1994) 1-407
47. Chu N.F., Spiegelman D., Hotamisligil G.S., et al. Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men. Atherosclerosis 157 (2001) 495-503
48. Fantuzzi G., and Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leuk Biol 68 (2000) 437-446
49. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
50. Ridker P.M., Wilson P.W., and Grundy S.M. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?. Circulation 109 (2004) 2818-2825
51. Verma S., Li S.H., Badiwala M.V., et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 105 (2002) 1890-1896
52. Baumann H., Morella K.K., White D.W., et al. The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc Natl Acad Sci USA 93 (1996) 8374-8378
53. Santos-Alvarez J., Goberna R., and Sanchez-Margalet V. Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 194 (1999) 6-11
54. Kern P.A., Ranganathan S., Li C., Wood L., and Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280 (2001) E745-E751
55. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
56. Kamath S., and Lip G.Y. Fibrinogen: biochemistry, epidemiology and determinants. QJM 96 (2003) 711-729
57. Balleisen L., Bailey J., Epping P.H., Schulte H., and van de Loo J. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population. I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause. Thromb Haemost 54 (1985) 475-479
58. Krobot K., Hense H.W., Cremer P., Eberle E., and Keil U. Determinants of plasma fibrinogen: relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex Results from the second MONICA Augsburg survey 1989-1990. Arterioscler Thromb 12 (1992) 780-788
59. Danesh J., Lewington S., Thompson S.G., et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 294 (2005) 1799-1809
60. Soderberg S., Olsson T., Eliasson M., Johnson O., and Ahren B. Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women. J Intern Med 245 (1999) 533-543
61. Kaufman J.S., Maclehose R.F., and Kaufman S. A further critique of the analytic strategy of adjusting for covariates to identify biologic mediation. Epidemiol Perspect Innov 1 (2004) 4
62. Riipi L., and Carlson E. Tumor necrosis factor (TNF) is induced in mice by Candida albicans: role of TNF in fibrinogen increase. Infect Immun 58 (1990) 2750-2754
63. Ruderman N., Chisholm D., Pi-Sunyer X., and Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes 47 (1998) 699-713
64. Murakami T., Michelagnoli S., Longhi R., et al. Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma. Arterioscler Thromb Vasc Biol 15 (1995) 1819-1828
65. Chavez J.A., Knotts T.A., Wang L.P., et al. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 278 (2003) 10297-10303
66. Kim Y.B., Shulman G.I., and Kahn B.B. Fatty acid infusion selectively impairs insulin action on Akt1 and protein kinase C lambda/zeta but not on glycogen synthase kinase-3. J Biol Chem 277 (2002) 32915-32922
67. Jensen M.D., Caruso M., Heiling V., and Miles J.M. Insulin regulation of lipolysis in nondiabetic and IDDM subjects. Diabetes 38 (1989) 1595-1601
68. Tack C.J., Smits P., Willemsen J.J., et al. Effects of insulin on vascular tone and sympathetic nervous system in NIDDM. Diabetes 45 (1996) 15-22
69. Simon C., Gronfier C., Schlienger J.L., and Brandenberger G. Circadian and ultradian variations of leptin in normal man under continuous enteral nutrition: relationship to sleep and body temperature. J Clin Endocrinol Metab 83 (1998) 1893-1899
70. Ahima R.S., Prabakaran D., Mantzoros C., et al. Role of leptin in the neuroendocrine response to fasting. Nature 382 (1996) 250-252
71. Pisu E., Diana A., Lombardi A., Cassader M., and Pagano G. Diurnal variations in insulin secretion and insulin sensitivity in aged subjects. Acta Diabetol Lat 17 (1980) 153-160